Answer
Kidney impairment can increase exposure and toxicity. Specialist assessment and closer monitoring are required, and use is not recommended in end-stage renal disease.
Sources for this answer
- Trifluridine/Tipiracil Servier — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.